Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexalin Technology (NXL) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $2.4 million.

  • Nexalin Technology's Operating Expenses fell 679.43% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 3514.65%. This contributed to the annual value of $7.9 million for FY2024, which is 3641.74% up from last year.
  • Per Nexalin Technology's latest filing, its Operating Expenses stood at $2.4 million for Q3 2025, which was down 679.43% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Nexalin Technology's Operating Expenses registered a high of $2.9 million during Q4 2024, and its lowest value of $651219.0 during Q3 2022.
  • For the 4-year period, Nexalin Technology's Operating Expenses averaged around $1.5 million, with its median value being $1.3 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 27401.81% in 2023, then tumbled by 679.43% in 2025.
  • Nexalin Technology's Operating Expenses (Quarter) stood at $751174.0 in 2022, then skyrocketed by 118.3% to $1.6 million in 2023, then soared by 76.55% to $2.9 million in 2024, then decreased by 18.49% to $2.4 million in 2025.
  • Its Operating Expenses stands at $2.4 million for Q3 2025, versus $1.7 million for Q2 2025 and $2.0 million for Q1 2025.